 Baudax Bio, Inc. BXRX the Company, a pharmaceutical company focused on therapeutics for acute care settings, today announced that due to the emerging health impact of the coronavirus pandemic, the Company has changed the location of its 2020 Annual Meeting of Stockholders the 2020 Annual Meeting to its corporate headquarters at 490 Lapp Road, Malvern, Pennsylvania 19355. Attendees may be subject to health screening procedures upon entering the building consistent with practices advised by governmental authorities or as otherwise in place for visitors to the Companys corporate office, and seating may be limited to comply with applicable social distancing guidelines. The Company urges all shareholders of record as of the Record Date of March 17, 2020 to promptly submit their proxy by executing and returning the proxy card previously mailed to them or by following the alternative voting procedures described on their proxy card. 